Related references
Note: Only part of the references are listed.Differential Presentation of Protein Interaction Surfaces on the Androgen Receptor Defines the Pharmacological Actions of Bound Ligands
John David Norris et al.
CHEMISTRY & BIOLOGY (2009)
Development of a Second-Generation Antiandrogen for Treatment of Advanced Prostate Cancer
Chris Tran et al.
SCIENCE (2009)
A surface on the androgen receptor that allosterically regulates coactivator binding
Eva Estebanez-Perpina et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
A promoting role of androgen receptor in androgen-sensitive and -insensitive prostate cancer cells
Tzu-Huey Li et al.
NUCLEIC ACIDS RESEARCH (2007)
Effects of flutamide as a second-line agent for maximum androgen blockade of hormone refractory prostate cancer
Kenji Nishimura et al.
INTERNATIONAL JOURNAL OF UROLOGY (2007)
ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor
Zhiming Yang et al.
NATURE MEDICINE (2007)
Cancer of the prostate
S Bracarda et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2005)
Correlation between in vitro peptide binding profiles and cellular activities for estrogen receptor-modulating compounds
MA Iannone et al.
MOLECULAR ENDOCRINOLOGY (2004)
Alternative antiandrogens to treat prostate cancer relapse after initial hormone therapy
S Kojima et al.
JOURNAL OF UROLOGY (2004)
Targeting the androgen receptor: improving outcomes for castration-resistant prostate cancer
HI Scher et al.
ENDOCRINE-RELATED CANCER (2004)
Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance
J Holzbeierlein et al.
AMERICAN JOURNAL OF PATHOLOGY (2004)
Regulation of PPARγ coactivator 1α (PGC-1α) signaling by an estrogen-related receptor α (ERRα) ligand
PJ Willy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Molecular determinants of resistance to antiandrogen therapy
CD Chen et al.
NATURE MEDICINE (2004)
Molecular characterization of human prostate carcinoma cell lines
A van Bokhoven et al.
PROSTATE (2003)
Use of homogeneous time-resolved fluorescence energy transfer in the measurement of nuclear receptor activation
GC Zhou et al.
METHODS (2001)
Antiandrogen withdrawal syndrome associated with prostate cancer therapies - Incidence and clinical significance
R Paul et al.
DRUG SAFETY (2000)